In a series of convergent lines of evidence we demonstrate that shorter ALS survival is associated with loss-of-function mutations within DNA2 and with reduced expression of DNA2 within iPSC-derived motor neurons. Here, DNA2 is linked to amyotrophic lateral sclerosis.